Trial
POETYK PSO-1
Deucravacitinib superior to placebo and apremilast in plaque psoriasis.
Sparsely connected — only 1 link recorded so far.

In short
- 1What it is: a trial in therapies and applications.
- 2How it connects: acts on 1 and is affected by 0 concepts — mostly 1 therapy.
- 3Where it sits: trial on the 15-step immune chain.
Its connections at a glance
Each dot is a concept directly linked to POETYK PSO-1. Colours show the kind of concept.
Learn next
Sources & evidenceloading…
Loading reviewed sources…
Graph ID TR024 · concept status: established. Select any connection above to inspect evidence for that specific link.